Strata Skin Sciences Inc SSKN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SSKN is a good fit for your portfolio.
News
-
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
-
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
-
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
-
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
-
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
-
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
-
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
Trading Information
- Previous Close Price
- $0.53
- Day Range
- $0.50–0.53
- 52-Week Range
- $0.26–1.14
- Bid/Ask
- $0.51 / $0.52
- Market Cap
- $18.04 Mil
- Volume/Avg
- 7,598 / 26,507
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 99
Valuation
|
Metric
|
SSKN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.42 |
Price/Sales | 0.54 |
Price/Cash Flow | — |
Price/Earnings
SSKN
Financial Strength
|
Metric
|
SSKN
|
|---|---|
Quick Ratio | 0.92 |
Current Ratio | 1.28 |
Interest Coverage | −5.80 |
Quick Ratio
SSKN
Profitability
|
Metric
|
SSKN
|
|---|---|
Return on Assets (Normalized) | −12.78% |
Return on Equity (Normalized) | −36.12% |
Return on Invested Capital (Normalized) | −16.19% |
Return on Assets
SSKN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gkpcwlhh | Dxyxbqb | $185.4 Bil | |
SYK
| Stryker Corp | Brpwzmth | Bqc | $127.7 Bil | |
BSX
| Boston Scientific Corp | Qrzpmslh | Fcmmvt | $107.6 Bil | |
MDT
| Medtronic PLC | Qyxnljld | Zmxrkn | $105.9 Bil | |
DXCM
| DexCom Inc | Sjrshpnfql | Ycypy | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Fgvxzjprf | Wlhqz | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xfbbrrzlnw | Gljtn | $24.6 Bil | |
ALGN
| Align Technology Inc | Wxdmptbxp | Rwkfpkj | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Zqrdfvgl | Lqprbl | $18.7 Bil | |
PODD
| Insulet Corp | Ggfdwrnr | Gxtrv | $11.6 Bil |